Ibuprofen-induced inhibition of cyclooxygenase isoform gene expression and regression of rat mammary carcinomas-Reference-Cited by-同舟云学术

Ibuprofen-induced inhibition of cyclooxygenase isoform gene expression and regression of rat mammary carcinomas

Published:1998-01 Issue:1-2 Volume:122 Page:165-175
ISSN:0304-3835
Container-title:Cancer Letters
language:en
Short-container-title:Cancer Letters

Author:

Robertson Fredika M,Parrett Michelle L,Joarder Farahnaz S,Ross Mary,Abou-Issa Hussein M,Alshafie Galal,Harris Randall E

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference40 articles.

1. In vivo effects of indomethacin on the growth of murine mammary tumors;Fulton;Cancer Res.,1984

2. A comparison of the effects of the prostaglandin synthesis inhibitors indomethacin and carprofen in 7,12 dimethylbenz(a)anthracene-induced mammary tumorigenesis in rats fed different amounts of essential fatty acids;Carter;Carcinogenesis,1989

3. Regulation of proliferation of rat mammary tumor cells by inhibitors of cyclooxygenase and lipoxygenase;Lee;Prostaglan. Leukotrien. Essen. Fat. Acid,1992

4. The role of fatty acids and eicoasanoid synthesis inhibitors in breast carcinoma;Noguchi;Oncology,1995

5. Effect of the prostaglandin synthetase inhibitor indomethacin on 7,12 dimethylbenz[a]anthracene-induced mammary tumorigenesis in rats fed different levels fat;Carter;Cancer Res.,1983

Cited by 61 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Contribution of non-steroidal anti-inflammatory drugs to breast cancer treatment: In vitro and in vivo studies;Veterinary World;2024-05

2. The Prostaglandin E2 Pathway and Breast Cancer Stem Cells: Evidence of Increased Signaling and Potential Targeting;Frontiers in Oncology;2022-01-19

3. Nonsteroidal anti-inflammatory drugs (NSAIDs) cause male-biased sex differentiation in zebrafish;Aquatic Toxicology;2020-06

4. Celecoxib promotes degranulation of CD8+ T cells in HPV-induced lesions of K14-HPV16 transgenic mice;Life Sciences;2016-07

5. COX-2 inhibitors: a novel strategy in the management of breast cancer;Drug Discovery Today;2016-04